Products Brought to Market
One of the Foundations’ missions is to transfer resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products. The following medical products, which have been developed based on discoveries by the Clayton Foundation, have been brought to market:
| Product / Company | Description | Depocyt
by
Pacira
| Therapeutic drug for cancer
DEPOCYT is a sustained release formulation of cytarabine approved for the treatment of lymphomatous meningitis.
Learn More
|  | Posicam Systems
by
Positron Corporation
| 
| PET imaging system
POSICAM™ systems incorporate patented and proprietary technology for the diagnosis and treatment of patients in the areas of oncology, cardiology and neurology.
Learn More
| RetCam II & RetCam Shuttle
by
Clarity Medical Systems
| Digital ophthalmic medical device
RetCam II and RetCam Shuttle are a major achievement in providing minaturized, integrated, wide-field imaging for management of eye disorders in infants
Learn More
| 
| Depodur
by
Pacira
| 
| Drug for time-released pain control
Depodur is the only extended-release morphine sulphate approved for epidural use in the treatment of postsurgical pain.
Learn More
|
| FIA – Functional Intracellular Analysis
by
SpectraCell
| Lymphocyte blood assay
SpectraCell's FIA™ is a clinically effective diagnostic tool for the prevention and management of chronic disease conditions.
Learn More
| 
|
| Autosomal Dominant Ataxia Evaluation
Complete Ataxia Evaluation
SCA6 DNA Test
by
Athena Diagnostics
| Neurogenetic diagnostic assay
Ataxia is characterized by poor coordination of hand, speech and eye movements, uncoordinated and unsteady gait. The test detects the triplet repeat expansion in nine known genes causing cerebellar ataxia, pentanucleotide repeat expansion in the sca6 gene.
Learn More
|
|